However, it is not clear whether the reduced tumor growth in KrasG12D;Ela-CreERT;Lcn2−/− mice was directly due to the lack of LCN2 effects on the pancreas or indirectly to the reduced weight gain (anti-obesity effects). Here, LCN2 is linked to obesity due to melanocortin 4 receptor deficiency.